Specialized formula medical nutrition refers to nutritional guidance that integrates medical and nutritional expertise, undergoes scientific formulation, strict quality inspection, and clinical validation. It aims to meet the nutritional needs for normal activities and growth and development of individuals with restricted eating, digestive and absorption disorders, metabolic disorders, or specific diseases. Medical nutrition involves multiple aspects, such as tumor nutrition, metabolic disease nutrition, digestive system disease nutrition, etc. Its diagnosis and treatment have involved all aspects.
Overview of Market Development
In recent years, the global specialized formula medical nutrition market has shown a steady growth trend, and the market size continues to expand. According to our research data, the global specialized formula medical nutrition market is expected to reach $20.64 billion in 2024, an increase of 7.14% compared to 2023. The main drivers of market growth include people's increasing awareness of health and nutrition, as well as the growing demand for functional foods and beverages.
In the future, with the continuous expansion of the application of medical nutrition in fields such as pediatrics, adult, and geriatric diseases, it is expected that the market will be further segmented and have enormous development potential. By 2029, the global specialized formula medical nutrition market is expected to increase in size to $28.42 billion. The CAGR for 2024-2029 is estimated to be 6.61%.
Analysis of Market Competition Pattern
From the perspective of market competition, the concentration of the global specialized formula medical nutrition market is moderate. According to the data, the total revenue share of the specialized formula medical nutrition market for the top 3 companies in 2023 was 43.99%. The top three companies are Abbott Laboratories, Danone, and Fresenius Kabi. In 2023, these three companies' revenue from the specialized formula medical nutrition market accounted for 15.73%, 15.07%, and 13.19% of the global market, respectively.
Global Specialized Formula Medical Nutrition Market Size Forecast and Competition Pattern Analysis
Source: www.globalmarketmonitor.com
Segmented Market Analysis
From the perspective of product types, the current global specialized formula medical nutrition market products are roughly divided into three categories: infant medical nutrition products, enteral medical nutrition products, and parenteral medical nutrition products. Among them, the sub category of enteral medical nutrition products holds the highest market share, estimated to be 50.82% in 2024.
From a regional perspective, the global specialized formula medical nutrition market is mainly concentrated in North America, Europe, and the Asia Pacific region. Among them, the Asia Pacific region is the largest revenue market. Data shows that the revenue of the specialized formula medical nutrition market in the Asia Pacific region is expected to reach $6.86 billion in 2024, with an estimated revenue share of 33.75%.
Global Specialized Formula Medical Nutrition Segment Market Revenue and Revenue Share Forecast in 2024
|
|
Market Revenue (Billion USD)
|
Revenue Share
|
|
Segmented by Type
|
|
Infant Medical Nutrition Products
|
2.67
|
12.93%
|
|
Enteral Medical Nutrition Products
|
10.49
|
50.82%
|
|
Parenteral Medical Nutrition Products
|
7.48
|
36.25%
|
|
Segmented by Region
|
|
North America
|
6.86
|
33.23%
|
|
Europe
|
5.06
|
24.53%
|
|
Asia Pacific
|
6.97
|
33.75%
|
|
South America
|
0.90
|
4.36%
|
|
Middle East & Africa
|
0.85
|
4.13%
|
Source: www.globalmarketmonitor.com
For more industry information, please refer to our latest released "2023 Global Specialized Formula Medical Nutrition Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast".
Chinese